Hostname: page-component-7b7567c8c-2n9c9 Total loading time: 0 Render date: 2026-11-17T10:42:53.470Z Has data issue: false hasContentIssue false

A comparative study of two live measles vaccines in Iran

Published online by Cambridge University Press:  15 May 2009

H. Mirchamsy
Affiliation:
Razi Serum Institute, P.O. Box 656, Tehran, Iran
A. Shafyi
Affiliation:
Razi Serum Institute, P.O. Box 656, Tehran, Iran
Y. Bassali
Affiliation:
Razi Serum Institute, P.O. Box 656, Tehran, Iran
S. Bahrami
Affiliation:
Razi Serum Institute, P.O. Box 656, Tehran, Iran
F. Nazari
Affiliation:
Razi Serum Institute, P.O. Box 656, Tehran, Iran
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

The results of immunization of 523 children from 9 months to over 5 years of age with two attenuated measles vaccines, ‘Denken’ and ‘Biken’, are described. The clinical reactions following vaccination with both vaccines were mild, but Denken vaccine produced more rashes than the Biken vaccine. The serological conversion was satisfactory for both vaccines but a higher titre of neutralizing and haemagglutination-inhibiting antibodies was found in children immunized with Denken vaccine. The incidence of severe reactions or complications was negligible in this trial. The immunity to diphtheria or tetanus was not altered by vaccination with live measles vaccine.

Information

Type
Research Article
Copyright
Copyright © Cambridge University Press 1970